Eli Lilly (NYSE: LLY)
Eli Lilly Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eli Lilly Company Info
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
News & Analysis
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
These stocks have climbed in the triple digits over the past few years.
Chesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.
1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today
Despite the company's run in recent years, it's not too late to buy.
Independence Bank of Kentucky Buys Another $3.1 Million Eli Lilly (NYSE: LLY) Shares
Should Investors Buy Eli Lilly Stock?
Investors are excited about the company's weight loss treatments but might be overlooking the exciting pipeline of new therapies.
The Largest Healthcare Companies by Market Cap in October 2025
Eli Lilly, Johnson & Johnson, and AbbVie command the healthcare sector.
Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market
Roche has a promising GLP-1 drug that is entering phase 3 trials.
Valuation
Podcast Episodes
The Problem With Weight Loss Stocks
There are new ways to tackle weight loss, but the stocks leading the way are lagging.
Is It Time to Buy Biotech Stocks?
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?
The State of Weight Loss Drugs
None
Nvidia, Apple, and Eli Lilly: Manufacturing the Future
The great buildout for AI and GLP-1 drugs continues.
Earnings Transcripts
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2024.
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript
LLY earnings call for the period ending September 30, 2024.
Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2024.
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.